Tech Company Financing Transactions
Ever/Body Funding Round
On 5/26/2021, Ever/Body raised $38 million in Series B funding from Tiger Global Management, Acme Nova and Addition Capital.
Transaction Overview
Company Name
Announced On
5/26/2021
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$38,000,000
Round
Series B
Investors
Tiger Global Management (Lead Investor)
Fifth Wall Ventures (Kevin Campos)
Proceeds Purpose
Additional funds will be used to enhance Ever/Body's proprietary technology and client experience, and invest in new services to expand its current treatment menu.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
453 W Bdwy.
New York, NY 10012
USA
New York, NY 10012
USA
Phone
Website
Email Address
Overview
In an industry that can be overwhelming and often overrun with misinformation, false promises, and asterisks, we founded EverBody to help you understand what's what. We founded our company to demystify cosmetic dermatology and make it more accessible.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Catherine Twist
Chief Executive Officer
Amy Shecter
Chief Operating Officer
William Acevedo
Chief Technical Officer
Karen Castelletti
Browse more venture capital transactions:
Prev: 5/26/2021: Verituity venture capital transaction
Next: 5/26/2021: IntelePeer venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs